PB-201
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PB-201, covering 2022-02-08 to 2022-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy [Phase 3]